Expiration Date: 11/05/2024
Learner Notification
*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.
Speakers
Alex Ponce, PharmD, BCEMP, DABAT
Emergency Medicine Clinical Pharmacist
WVU Medicine Ruby Memorial Hospital
Rob Seabury, PharmD, BCPS, DABAT
Clinical Staff Pharmacist, Emergency Medicine
Upstate University Hospital
Moderator
Adam Overberg, MD
Managing Director, Indiana Poison Center
Indiana University Health Methodist Hospital
Has disclosed no relevant financial relationships
Organizer
David Vearrier, MD, MPH
Professor of Emergency Medicine
University of Mississippi Medical Center
Description
Drs. Ponce and Seabury will discuss the following articles:
• Senart AM, LeClair LA. Cardiovascular and Adverse Effects of Glucagon for the Management of Suspected Beta Blocker
Toxicity: a Case Series. J Med Toxicol. 2023 Jan;19(1):9-15. doi: 10.1007/s13181-022-00919-x. Epub 2022 Dec 7. PMID:
36479689; PMCID: PMC9813284.
• Kerns W 2nd, Schroeder D, Williams C, Tomaszewski C, Raymond R. Insulin improves survival in a canine model of acute
beta-blocker toxicity. Ann Emerg Med. 1997 Jun;29(6):748-57. doi: 10.1016/s0196-0644(97)70196-3. PMID: 9174520
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles, and complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. You must participate in the entire activity as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
Amedco LLC designates this material for a maximum of 1.00 AMA PRA Category 1 CreditsTM for physicians. Physicians
should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists & Pharmacy Technicians
Amedco LLC designates this activity for a maximum of 1.00 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
Objectives - After attending this program you should be able to:
- Evaluate the impact of glucagon on heart rate and blood pressure
- Discuss adverse effects associated with glucagon therapy for the treatment of beta blocker toxicity
- Recognize the potential survival difference with high-dose insulin versus glucagon in severe beta-blocker poisoning.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco.